Selection of Recent Oncology Articles Published in The Lancet

On this page, you will find links to the latest oncology-related research articles published in The Lancet.

Filter

Date Title Topic
21 Oct 2017 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNO... Cancer Immunology and Immunotherapy , Melanoma and other Skin Tumours
20 Oct 2017 PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 t... Haematologic Malignancies , Lymphomas , Imaging, Diagnosis and Staging
05 Oct 2017 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemothera... Cancer Immunology and Immunotherapy , Gastrointestinal Cancers , Gastric Cancer
12 Sep 2017 Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based... Cancer Immunology and Immunotherapy , Genitourinary Cancers , Urothelial Cancers
12 Sep 2017 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-co... Cancer Immunology and Immunotherapy , Gynaecologic Malignancies , Ovarian Cancer
09 Sep 2017 CAR T-cells: an exciting frontier in cancer therapy. Cancer Immunology and Immunotherapy , Translational Research
08 Aug 2017 Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted an... Anti-Cancer Agents & Biologic Therapy , Central Nervous System Malignancies
29 Jul 2017 Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Anti-Cancer Agents & Biologic Therapy , Gastrointestinal Cancers , Rectal Cancer , Surgery and/or Radiotherapy of Cancer
27 Jul 2017 Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial... Cancer Immunology and Immunotherapy , Gynaecologic Malignancies , Cervical Cancer
01 Jul 2017 J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer. Cancer Immunology and Immunotherapy , Lung and other Thoracic Tumours
22 Jun 2017 Oesophageal cancer. Gastrointestinal Cancers , Oesophageal Cancer
17 Jun 2017 Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Breast Cancer , Translational Research
17 Jun 2017 Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. Breast Cancer
20 May 2017 Computer-assisted diagnosis for skin cancer: have we been outsmarted? Melanoma and other Skin Tumours , Translational Research
25 Apr 2017 Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansi... Cancer Immunology and Immunotherapy , Gastrointestinal Cancers , Hepatobiliary Cancers